"Designing Growth Strategies is in our DNA"

U.S. Autism Spectrum Disorder Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Therapy (Antipsychotic Drugs, SSRIs/Antidepressants, Stimulants, Sleep Medications, and Others), By Disease (Autistic Disorder, Asperger Syndrome, Pervasive Developmental Disorder, and Others), By Age Group (Children and Adults), By Distribution Channel (Hospital Pharmacies, Drugs Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: February 17, 2025 | Format: PDF | Report ID: FBI108931

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Autism Spectrum Disorder, 2022
    2. Key Industry Developments (Mergers, Acquisition and Partnerships)
    3. Pipeline Analysis, By Key Players
    4. Economic Cost Burden for the Treatment of Autism Spectrum Disorder
    5. Impact of Covid-19 on the Market
  5. U.S. Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2019-2030 
    1. Market Analysis, Insights and Forecast – By Drug Therapy
      1. Antipsychotic Drugs
      2. SSRIs/Antidepressants
      3. Stimulants
      4. Sleep Medications
      5. Others
    2. Market Analysis, Insights and Forecast – By Disease
      1. Autistic Disorder
      2. Asperger Syndrome
      3. Pervasive Development Disorder (PDD)
      4. Others
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Children
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Curemark, LLC
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Alembic Pharmaceuticals Limited.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Yamo Pharmaceuticals
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. PaxMedica
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Aurobindo Pharma Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Otsuka Pharmaceutical Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Janssen Pharmaceuticals, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. H. Lundbeck A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Drug Therapy, 2019–2030

Table 02: U.S. Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Disease, 2019–2030

Table 03: U.S. Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Age Group, 2019–2030

Table 04: U.S. Autism Spectrum Disorder Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019–2030

Figure 01:  U.S. Autism Spectrum Disorder Therapeutics Market Revenue Breakdown (USD billion, %), By Drug Therapy, 2022 & 2030

Figure 02: U.S. Autism Spectrum Disorder Therapeutics Market Value Share (%), By Drug Therapy, 2022 & 2030

Figure 03: U.S. Autism Spectrum Disorder Therapeutics Market Value Share (%), By Disease, 2022 & 2030

Figure 04: U.S. Autism Spectrum Disorder Therapeutics Market Value Share (%), By Age Group, 2022 & 2030

Figure 05: U.S. Autism Spectrum Disorder Therapeutics Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 06:  U.S. Autism Spectrum Disorder Therapeutics Market Share (%), 2022

U.S. Autism Spectrum Disorder Therapeutics Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 80
Consulting Services
    How will you benefit from our consulting services ?